Home » Topics » Regulatory » Patents

Patents
RSS

Pharma Mar isolates new cytotoxic agents from marine sponge

May 6, 1997

Squalene synthase inhibitors reported by Takeda

May 6, 1997

Sanofi claims HLE inhibitors

May 6, 1997

Pierre Fabre prepares agents with antidopaminergic/antiserotonergic effects

May 5, 1997

Lp-PLA2 inhibitors from SmithKline Beecham

May 5, 1997

Hypolipidemic triterpenes claimed by Leo

May 5, 1997

Inhibitors of 5alpha-reductase from Pharmacia & Upjohn

May 5, 1997

SKB reveals metallo-beta-lactamase inhibitors

May 5, 1997

Dual D2/beta2 agonists disclosed by Astra

May 5, 1997

Agents specific for dopamine D3 receptors described by Neurogen

May 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...